Novo Nordisk initiates share repurchase
- Share repurchase program started on 6 May 2026
- Up to DKK 11.2 billion for B shares until 1 Feb 2027
- Repurchased 23,090,000 B shares as of 9 Oct 2026
NONOF
NOVO NORDISK A S SEC filings
Every EDGAR filing for NOVO NORDISK A S (NONOF), newest first, with AI summaries and stories.
- Ticker
- NONOF
- CIK
- 353278
- Latest filing
- 6d
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE6-KNOVO NORDISK A SNONOFLIVE ROUTINE6-KNOVO NORDISK A SNONOFLIVE NOVO NORDISK A S initiates share repurchase
- Share repurchase program up to DKK 15 billion
- Repurchased B shares worth DKK 6.4 billion as of 2 October 2026
- Owns 1.1% of share capital as treasury shares
ROUTINE6-KNOVO NORDISK A SNONOFLIVE Novo Nordisk updates on denecimig BLA review
- FDA says BLA review for denecimig is ongoing
- FDA cites facility remediation as reason for delay
- No impact on 2026 financial outlook
ROUTINE6-KNOVO NORDISK A SNONOFLIVE ROUTINE6-KNOVO NORDISK A SNONOFLIVE ROUTINE6-KNOVO NORDISK A SNONOFLIVE ROUTINE6-KNOVO NORDISK A SNONOFLIVE ROUTINE6-KNOVO NORDISK A SNONOFLIVE ROUTINE6-KNOVO NORDISK A SNONOFLIVE ROUTINE6-KNOVO NORDISK A SNONOFLIVE ROUTINE6-KNOVO NORDISK A SNONOFLIVE ROUTINE6-KNOVO NORDISK A SNONOFLIVE ROUTINE6-KNOVO NORDISK A SNONOFLIVE ROUTINE6-KNOVO NORDISK A SNONOFLIVE ROUTINE6-KNOVO NORDISK A SNONOFLIVE ROUTINE6-KNOVO NORDISK A SNONOFLIVE ROUTINE6-KNOVO NORDISK A SNONOFLIVE ROUTINE6-KNOVO NORDISK A SNONOFLIVE ROUTINE6-KNOVO NORDISK A SNVOLIVE ROUTINE6-KNOVO NORDISK A SNVOLIVE ROUTINE6-KNOVO NORDISK A SNONOFLIVE ROUTINE6-KNOVO NORDISK A SNVOLIVE ROUTINE6-KNOVO NORDISK A SNONOFLIVE ROUTINESCHEDULE 13G/AInnate Pharma SAIPHYFLIVE Ownership stake disclosure by Nordisk A S Novo (amended)
Nordisk A S Novo, filed by
ROUTINE6-KNOVO NORDISK A SNVOLIVE ROUTINE6-KNOVO NORDISK A SNONOFLIVE ROUTINE6-KNOVO NORDISK A SNVOLIVE ROUTINE6-KNOVO NORDISK A SNONOFLIVE ROUTINE6-KNOVO NORDISK A SNVOLIVE ROUTINESDNOVO NORDISK A SNVOLIVE ROUTINE6-KNOVO NORDISK A SNVOLIVE ROUTINE6-KNOVO NORDISK A SNVOLIVE ROUTINE6-KNOVO NORDISK A SNONOFLIVE ROUTINE6-KNOVO NORDISK A SNVOLIVE ROUTINE6-KNOVO NORDISK A SNONOFLIVE ROUTINE6-KNOVO NORDISK A SNONOFLIVE ROUTINE6-KNOVO NORDISK A SNVOLIVE ROUTINE6-KNOVO NORDISK A SNVOLIVE ROUTINE6-KNOVO NORDISK A SNONOFLIVE ROUTINESCHEDULE 13G/AInnate Pharma SAIPHYFLIVE Ownership stake disclosure by Nordisk A S Novo (amended)
Nordisk A S Novo, filed by
ROUTINE6-KNOVO NORDISK A SNVOLIVE ROUTINE6-KNOVO NORDISK A SNONOFLIVE ROUTINE6-KNOVO NORDISK A SNVOLIVE ROUTINE6-KNOVO NORDISK A SNVOLIVE ROUTINE6-KNOVO NORDISK A SNONOFLIVE ROUTINE6-KNOVO NORDISK A SNVOLIVE ROUTINE6-KNOVO NORDISK A SNONOFLIVE ROUTINE6-KNOVO NORDISK A SNVOLIVE ROUTINE6-KNOVO NORDISK A SNVOLIVE ROUTINESCHEDULE 13G/AInnate Pharma SAIPHYFLIVE Ownership stake disclosure by Nordisk A S Novo (amended)
Nordisk A S Novo, filed by